305 related articles for article (PubMed ID: 21825246)
41. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Bataller L; Suárez-Calvet M; Saiz A; Dalmau J; Graus F
J Neuroimmunol; 2008 Sep; 201-202():163-5. PubMed ID: 18639938
[TBL] [Abstract][Full Text] [Related]
42. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
[TBL] [Abstract][Full Text] [Related]
43. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.
Raspotnig M; Haugen M; Thorsteinsdottir M; Stefansson I; Salvesen HB; Storstein A; Vedeler CA
Cancer Immunol Immunother; 2017 Nov; 66(11):1463-1471. PubMed ID: 28710511
[TBL] [Abstract][Full Text] [Related]
44. Acute onset paraneoplastic cerebellar degeneration.
Bonakis A; Papageorgiou SG; Mandellos D; Galani E; Kalfakis N
J Neurooncol; 2007 Sep; 84(3):329-30. PubMed ID: 17638062
[No Abstract] [Full Text] [Related]
45. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
46. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
Phuphanich S; Brock C
J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
[TBL] [Abstract][Full Text] [Related]
47. Anti-Yo autoimmunity; dangerous for the brain but not the tumor?
Greenlee JE
J Neurol Sci; 2006 Dec; 250(1-2):1-2. PubMed ID: 17010383
[No Abstract] [Full Text] [Related]
48. [Paraneoplastic cerebellar degeneration].
Sakai K
Brain Nerve; 2010 Apr; 62(4):357-64. PubMed ID: 20420175
[TBL] [Abstract][Full Text] [Related]
49. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
50. Proteasome antibodies in paraneoplastic cerebellar degeneration.
Storstein A; Knudsen A; Vedeler CA
J Neuroimmunol; 2005 Aug; 165(1-2):172-8. PubMed ID: 15964637
[TBL] [Abstract][Full Text] [Related]
51. Protein kinase Cγ antibodies and paraneoplastic cerebellar degeneration.
Höftberger R; Kovacs GG; Sabater L; Nagy P; Racz G; Miquel R; Dalmau J; Graus F
J Neuroimmunol; 2013 Mar; 256(1-2):91-3. PubMed ID: 23273977
[TBL] [Abstract][Full Text] [Related]
52. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy.
Sillevis Smitt P; Grefkens J; de Leeuw B; van den Bent M; van Putten W; Hooijkaas H; Vecht C
J Neurol; 2002 Jun; 249(6):745-53. PubMed ID: 12111309
[TBL] [Abstract][Full Text] [Related]
53. [Anti-Ma2-associated encephalitis and paraneoplastic limbic encephalitis].
Yamamoto T; Tsuji S
Brain Nerve; 2010 Aug; 62(8):838-51. PubMed ID: 20714032
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to Delta/notch-like epidermal growth factor-related receptor in patients with anti-Tr, paraneoplastic cerebellar degeneration, and Hodgkin lymphoma.
Greene M; Lai Y; Baella N; Dalmau J; Lancaster E
JAMA Neurol; 2014 Aug; 71(8):1003-8. PubMed ID: 24935874
[TBL] [Abstract][Full Text] [Related]
55. Ataxic vs painful form of paraneoplastic neuropathy.
Oki Y; Koike H; Iijima M; Mori K; Hattori N; Katsuno M; Nakamura T; Hirayama M; Tanaka F; Shiraishi M; Yazaki S; Nokura K; Yamamoto H; Sobue G
Neurology; 2007 Aug; 69(6):564-72. PubMed ID: 17679675
[TBL] [Abstract][Full Text] [Related]
56. Antibodies to Zic4 in paraneoplastic neurologic disorders and small-cell lung cancer.
Bataller L; Wade DF; Graus F; Stacey HD; Rosenfeld MR; Dalmau J
Neurology; 2004 Mar; 62(5):778-82. PubMed ID: 15007130
[TBL] [Abstract][Full Text] [Related]
57. Endometrial carcinoma first presenting as paraneoplastic cerebellar degeneration.
Erez Y; Rojansky N; Shveiky D; Ben-Meir A; Benshushan A
Gynecol Oncol; 2007 Jun; 105(3):826-7. PubMed ID: 17428523
[TBL] [Abstract][Full Text] [Related]
58. An interferon-gamma ELISPOT and immunohistochemical investigation of cytotoxic T lymphocyte-mediated tumour immunity in patients with paraneoplastic cerebellar degeneration and anti-Yo antibodies.
Sutton IJ; Steele J; Savage CO; Winer JB; Young LS
J Neuroimmunol; 2004 May; 150(1-2):98-106. PubMed ID: 15081253
[TBL] [Abstract][Full Text] [Related]
59. Anti-Ma-associated paraneoplastic cerebellar degeneration in a patient with nodular lymphocyte-predominant Hodgkin lymphoma: a case report.
Inui R; Saito K; Shimomura Y; Yamashita D; Kawamoto M; Ishikawa T
BMC Neurol; 2020 Sep; 20(1):355. PubMed ID: 32967629
[TBL] [Abstract][Full Text] [Related]
60. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
